2018-10-08 Comments Off on Neoadjuvant combination checkpoint blockade trial yields high response rates for patients with stage 3 melanoma Neoadjuvant combination checkpoint blockade trial yields high response rates for patients with stage 3 melanoma Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high